• British Pharmacopoeia Volume I & II
  • Monographs: Medicinal and Pharmaceutical Substances

Amantadine Hydrochloride

European Union chaplet of stars
General Notices

(Ph Eur monograph 0463)

bp2012_v1_07_medicinal_and_pharmaceutical_substances_1 amantadinehydrochloride_1_2012_70_cs.png


C10H17N,HCl    187.7    665-66-7

Action and use

Viral replication inhibitor (influenza A); dopamine receptor agonist; treatment of influenza and Parkinson's disease.

Preparations

Amantadine Capsules

Amantadine Oral Solution

Ph Eur

DEFINITION

Tricyclo[3.3.1.13,7]decan-1-amine hydrochloride.

Content

98.5 per cent to 101.0 per cent (anhydrous substance).

CHARACTERS
Appearance

White or almost white, crystalline powder.

Solubility

Freely soluble in water and in ethanol (96 per cent).

It sublimes on heating.

IDENTIFICATION

First identification  A, D.

Second identification  B, C, D.

A. Infrared absorption spectrophotometry (2.2.24).

Preparation  Discs.

Comparison  amantadine hydrochloride CRS.

B. To 0.1 g add 1 mL of pyridine R, mix and add 0.1 mL of acetic anhydride R. Heat to boiling for about 10 s. Pour the hot solution into 10 mL of dilute hydrochloric acid R, cool to 5 °C and filter. The precipitate, washed with water R and dried in vacuo at 60 °C for 1 h, melts (2.2.14) at 147 °C to 151 °C.

C. Dissolve 0.2 g in 1 mL of 0.1 M hydrochloric acid. Add 1 mL of a 500 g/L solution of sodium nitrite R. A white precipitate is formed.

D. 1 mL of solution S (see Tests) gives reaction (a) of chlorides (2.3.1).

TESTS
Solution S

Dissolve 2.5 g in carbon dioxide-free water R and dilute to 25 mL with the same solvent.

Appearance of solution

Solution S is clear (2.2.1) and not more intensely coloured than reference solution Y7 (2.2.2, Method II).

Acidity or alkalinity

Dilute 2 mL of solution S to 10 mL with carbon dioxide-free water R. Add 0.1 mL of methyl red solution R and 0.2 mL of 0.01 M sodium hydroxide. The solution is yellow. Add 0.4 mL of 0.01 M hydrochloric acid. The solution is red.

Related substances

Gas chromatography (2.2.28): use the normalisation procedure.

Test solution  Dissolve 0.10 g of the substance to be examined in 2 mL of water R. Add 2 mL of a 200 g/L solution of sodium hydroxide R and 2 mL of chloroform R. Shake for 10 min. Separate the chloroform layer, dry over anhydrous sodium sulfate R and filter.

Column:
  • material: glass;
  • size  = 1.8 m, Ø = 2 mm;
  • stationary phase: mix 19.5 g of silanised diatomaceous earth for gas chromatography R with 60 mL of a 3.3 g/L solution of potassium hydroxide R in methanol R and evaporate the solvent under reduced pressure while rotating the mixture slowly (support); dissolve 0.4 g of low-vapour-pressure hydrocarbons (type L) R in 60 mL of toluene R (dissolution requires up to 5 h), add this solution to the support and evaporate the solvent under reduced pressure while rotating the mixture slowly.

Carrier gas  nitrogen for chromatography R.

Flow rate  30 mL/min.

Temperature:

bp2012_v1_07_medicinal_and_pharmaceutical_substances_1 amantadinehydrochloride_2_2012_70_tb.png


Detection  Flame ionisation.

Injection  1 µL or the chosen volume.

Run time  At least 2.5 times the retention time of amantadine.

Limits:
  • any impurity: for each impurity, maximum 0.3 per cent;
  • total: maximum 1 per cent;
  • disregard limit: disregard the peak due to the solvent.

Maximum 20 ppm.

12 mL of solution S complies with test A. Prepare the reference solution using lead standard solution (2 ppm Pb) R.

Water (2.5.12)

Maximum 0.5 per cent, determined on 2.000 g.

Sulfated ash (2.4.14)

Maximum 0.1 per cent, determined on 1.0 g.

ASSAY

Dissolve 0.150 g in a mixture of 5.0 mL of 0.01 M hydrochloric acid and 50 mL of ethanol (96 per cent) R. Carry out a potentiometric titration (2.2.20), using 0.1 M sodium hydroxide. Read the volume added between the 2 points of inflexion.

1 mL of 0.1 M sodium hydroxide is equivalent to 18.77 mg of C10H18ClN.

Ph Eur